21 CFR 640.30
§ 640.30 Plasma.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 640.30, § 640.30 Plasma, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88484
- Permanent ID
ys:prov:88484@1- SHA-256
49c4f37febbad32d02a7103ca2301e787af2d4068e5f87abeaf307bd411f3381
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Proper name and definition. The proper name of this component is Plasma. The component is defined as:
(1) The fluid portion of one unit of human blood intended for intravenous use which is collected in a closed system, stabilized against clotting, and separated from the red cells; or
(2) The fluid portion of human blood intended for intravenous use which is prepared by apheresis methods as specified in the directions for use for the blood collecting, processing, and storage system including closed and open systems.
(b) Source.
(1) Plasma shall be obtained by separating plasma from blood collected from blood donors or by plasmapheresis.
(2) Plasma may be obtained from a unit of Whole Blood collected by another licensed establishment.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.